Literature DB >> 26319340

Uveitis.

James P Dunn1.   

Abstract

Multidisciplinary management in the diagnosis and management of patients with ocular inflammatory disease is often critical. The workup of uveitis or scleritis may reveal an underlying systemic disease. Recognition of inflammation by the primary care physician can facilitate prompt referral to a uveitis specialist and improve patient outcomes. The primary care physician can assist the ophthalmologist in monitoring for potential side effects of corticosteroids and immunosuppressive drugs, including the newer biologic agents. The ophthalmologist in turn can assist the primary care physician in recognizing that active uveitis may suggest incomplete control of preexisting conditions.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biologics; Corticosteroids; Immunosuppressive therapy; Multidisciplinary management; Ocular inflammatory disease; Scleritis; Uveitis

Mesh:

Substances:

Year:  2015        PMID: 26319340     DOI: 10.1016/j.pop.2015.05.003

Source DB:  PubMed          Journal:  Prim Care        ISSN: 0095-4543            Impact factor:   2.907


  13 in total

Review 1.  IL-6 blockade in the management of non-infectious uveitis.

Authors:  Giuseppe Lopalco; Claudia Fabiani; Jurgen Sota; Orso Maria Lucherini; Gian Marco Tosi; Bruno Frediani; Florenzo Iannone; Mauro Galeazzi; Rossella Franceschini; Donato Rigante; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2017-05-20       Impact factor: 2.980

2.  Contrast-enhanced T2-FLAIR MR imaging in patients with uveitis.

Authors:  Diego A Herrera; Sergio Franco; Sebastián Bustamante; Sergio A Vargas; Martin Ochoa-Escudero; Arthur B Dublin; Miguel Cuevas
Journal:  Int Ophthalmol       Date:  2016-07-12       Impact factor: 2.031

3.  Red Eye: A Guide for Non-specialists.

Authors:  Andreas Frings; Gerd Geerling; Marc Schargus
Journal:  Dtsch Arztebl Int       Date:  2017-04-28       Impact factor: 5.594

Review 4.  The emerging role of interleukin (IL)-1 in the pathogenesis and treatment of inflammatory and degenerative eye diseases.

Authors:  Claudia Fabiani; Jurgen Sota; Gian Marco Tosi; Rossella Franceschini; Bruno Frediani; Mauro Galeazzi; Donato Rigante; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2016-12-28       Impact factor: 2.980

Review 5.  Topical mydriatics as adjunctive therapy for traumatic iridocyclitis.

Authors:  Jeffrey Hom; Salman Sarwar; Mona A Kaleem; Catherine R Messina; Samuel A Abariga; Quan Dong Nguyen
Journal:  Cochrane Database Syst Rev       Date:  2020-08-25

6.  Development and Validation of a Model to Predict Anterior Segment Vision-Threatening Eye Disease Using Primary Care Clinical Notes.

Authors:  Karandeep Singh; Alexa Thibodeau; Leslie M Niziol; Tejpreet K Nakai; Jill E Bixler; Mariam Khan; Maria A Woodward
Journal:  Cornea       Date:  2021-10-05       Impact factor: 3.152

7.  Is uveitis associated with topiramate use? A cumulative review.

Authors:  Jeffrey L Goldberg; Amy G Lau; Bo Fan; Lisa Ford; Howard E Greenberg
Journal:  Clin Ophthalmol       Date:  2016-08-02

8.  A novel bispecific molecule delivered by recombinant AAV2 suppresses ocular inflammation and choroidal neovascularization.

Authors:  Yiming Li; Ping Zhu; Amrisha Verma; Tuhina Prasad; Hongxin Deng; Dechao Yu; Qiuhong Li
Journal:  J Cell Mol Med       Date:  2017-03-22       Impact factor: 5.310

Review 9.  Turning Down the Thermostat: Modulating the Endocannabinoid System in Ocular Inflammation and Pain.

Authors:  James T Toguri; Meggie Caldwell; Melanie E M Kelly
Journal:  Front Pharmacol       Date:  2016-09-15       Impact factor: 5.810

Review 10.  Profile of adalimumab and its potential in the treatment of uveitis.

Authors:  Stephen J Balevic; C Egla Rabinovich
Journal:  Drug Des Devel Ther       Date:  2016-09-19       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.